Scottish Provident introduces market leading critical illness definitions
Scottish Provident today announced substantial changes to its critical illness definitions as part of its pledge to redefine the protection market.
The changes, which are effective as of 23 May, mean that it now offers additional cover for low grade prostate cancer and an early form of breast cancer known as ductal carinoma in situ (DCIS). While most other providers only cover mastectomy, the new Scottish Provident definition means that the more common treatment for DCIS, a lumpectomy, is also covered.
As part of the changes Scottish Provident has also introduced five new definitions - two of which are completely new to the critical illness market. These are:
Intensive care - requiring mechanical ventilation for 10 consecutive days (new to critical illness market)
Pneumonectomy - removal of a complete lung (new to critical illness market)
Encephalitis - resulting in permanent symptoms
Multiple system atrophy - resulting in permanent symptoms
Systemic lupus erythematosus - with severe complications
Susan Barclay, Head of Marketing, Scottish Provident, said: "We recognise the importance of providing the best definitions combined with a wider breadth of cover, ultimately leading to paying more claims to our customers when they need it. We are committed to putting Scottish Provident at the forefront of the protection market by continually pushing the boundaries.
The changes we have announced today mean that customers receive an even better deal, reinforcing their financial safety net and providing them with peace of mind should they become critically ill. This is all part of our commitment to offering the most comprehensive range of critical illness products at cost effective pricing."
A further two of Scottish Provident's existing definitions are ABI+ meaning nine now exceed the industry standard, five of which were in the company's top ten reasons for claiming during 2010
|
